DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes | Molecular Cancer | Full Text https://t.co/xaxQzKFsaz
974 followers
29 followers
A joint collaborative effort led by Prof Navin from @NTU_LKCMedicine, uncovering the role of the loss of DDX3X and its association with chemoresistance in DLBCL. Check it out here! https://t.co/RlCnUzeKt4
2,454 followers
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes #lymphoma #lymsm https://t.co/zG1nco7U2E
2,454 followers
DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes #lymphoma #lymsm https://t.co/hfCXc4WfwA